Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhe Fu

Showing results (141-150 of 146) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 146 results.
Blood Cancer Journal|November 6, 2024
The third generation AKR1C3-activated prodrug, ACHM-025, eradicates disease in preclinical models of aggressive T-cell acute lymphoblastic leukemiaCara E Toscan, Hannah McCalmont, Amir Ashoorzadeh, et al.
NPJ Digital Medicine|October 16, 2023
DeepQuality improves infant retinopathy screeningLonghui Li, Duoru Lin, Zhenzhe Lin, et al.
Zoological Research|September 29, 2025
Ultra-short cyclic peptide Cy <sub>RL-QN15</sub> acts as a TLR4 antagonist to expedite oral ulcer healingZe-Qiong Ru, Yu-Tong Wu, Chong-Yu Yang, et al.
The British Journal of Ophthalmology|June 5, 2024
Digital ray: enhancing cataractous fundus images using style transfer generative adversarial networks to improve retinopathy detectionLixue Liu, Jiaming Hong, Yuxuan Wu, et al.
Molecular Cancer Therapeutics|October 9, 2021
Selectively Targeting Tumor Hypoxia With the Hypoxia-Activated Prodrug CP-506Alexander M A van der Wiel, Victoria Jackson-Patel, Raymon Niemans, et al.
Nature|September 17, 2025
DeepSeek-R1 incentivizes reasoning in LLMs through reinforcement learningDaya Guo, Dejian Yang, Haowei Zhang, et al.
Pageof 15

Showing results (141-150 of 146) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 146 results.
Blood Cancer Journal|November 6, 2024
The third generation AKR1C3-activated prodrug, ACHM-025, eradicates disease in preclinical models of aggressive T-cell acute lymphoblastic leukemiaCara E Toscan, Hannah McCalmont, Amir Ashoorzadeh, et al.
NPJ Digital Medicine|October 16, 2023
DeepQuality improves infant retinopathy screeningLonghui Li, Duoru Lin, Zhenzhe Lin, et al.
Zoological Research|September 29, 2025
Ultra-short cyclic peptide Cy <sub>RL-QN15</sub> acts as a TLR4 antagonist to expedite oral ulcer healingZe-Qiong Ru, Yu-Tong Wu, Chong-Yu Yang, et al.
The British Journal of Ophthalmology|June 5, 2024
Digital ray: enhancing cataractous fundus images using style transfer generative adversarial networks to improve retinopathy detectionLixue Liu, Jiaming Hong, Yuxuan Wu, et al.
Molecular Cancer Therapeutics|October 9, 2021
Selectively Targeting Tumor Hypoxia With the Hypoxia-Activated Prodrug CP-506Alexander M A van der Wiel, Victoria Jackson-Patel, Raymon Niemans, et al.
Nature|September 17, 2025
DeepSeek-R1 incentivizes reasoning in LLMs through reinforcement learningDaya Guo, Dejian Yang, Haowei Zhang, et al.
Pageof 15